Keynote Lectures (1) Current Challenges of Antimicrobial Treatment : Lessons from the 20th Century

Global Overview of Antimicrobial Resistance : Historical Perspectives Jae-Hoon Song (Samsung Medical Center, Sungkyunkwan Univ., Korea)

Bacterial Resistance : The Fight We Cannot Win Jean-Claude Pechere (Univ. of Geneva, Switzerland)

Dynamics of the Evolution of Antimicrobial Resistance Barbara E. Murray (Univ. of Texas, USA)

New Therapeutic Options from Current Antimicrobial Armamentarium Walter R. Wilson (Mayo Clinic, USA)

The Terrible Impact of AIDS on Africa : The Case for Prevention and Treatment Now! Merle Sande (Univ. of Utah, USA)

HIV Dynamics and Challenges for Antiretroviral Therapy Zelalem Temesgen (Mayo Clinic, USA)

Severe Acute Respiratory Syndrome (SARS) : New Plague in the 21st Century Joseph Sung (P.R. China)

Session A Pneumococcal Resistance In Conjunction with Infectious Diseases Society of the Republic of China

Pneumococcal Resistance to Beta-Lactams and Macrolides Jae-Hoon Song (Samsung Medical Center, Sungkyunkwan Univ., Korea)

Pneumococcal Resistance to Fluoroquinolones Donald E. Low (Mount Sinai Hospital, Canada)

Clinical Implications : Pneumonia and Meningitis Keith P. Klugman (Emory Univ., USA)

Clinical Implications : Otitis Media Ron Dagan (Soroka Univ. Medical Center, Israel)

Session B Resistance in Gram-Negative Bacilli

Beta-Lactamases & ESBLs Karen Bush (Johnson & Johnson Pharmaceutical Research & Development, USA)

Metallo-Beta-Lactamase & Carbapenemases David M. Livermore  (Central Public Health Laboratory, U.K.)

Laboratory Detection of ESBLs : Issues and Problems Kyungwon Lee (Yonsei Univ., Korea)

Clinical Inplications of ESBLs Hyunjoo Pai (Hanyang Univ.,Korea)

Session C Clinical Microbiology Lab in the Era of Antibiotic Resistance : Current Issues and Future Trends

Antimicrobial Susceptibility Test : A Reappraisal Eui-Chong Kim (Seoul National Univ., Korea)

Genotypic Susceptibility Testing : Principles and Practices Franklin R. Cockerill (Mayo Clinic, USA)

Molecular Typing of Antibiotic-Resistant Bacteria Cheng-Hsun Chiu (Chang Gung Children's Hospital, Chinese Taipei)

DNA Microarray for Detection of Resistance Yeonhee Lee (Seoul Women's Univ., Korea)

Session D Enterococcal Resistance In conjunction with Korean Society of Infections Diseases

The Enterococci: a Continuing Therapeutic Challenge. Barbara E. Murray (Univ. of Texas, USA)

Mechanisms of Glycopeptide and Oxazolidinone Resistance in Enterococci Wee Gyo Lee (Ajou Univ., Korea)

Clinical Implications of Glycopeptide-Resistant Enterococci Walter R. Wilson (Mayo Clinic, USA)

Session E Current Issues in the Management of Serious Fungal Infections

Antifungal Resistance : How big is the problem? Thomas F. Patterson (Univ. of Texas Health Science Center, USA)

Treatment of Systemic Candidal Infection William E. Dismukes (Univ. of Alabama, USA)

Treatment of Invasive Aspergillosis Thomas F. Patterson (Univ. of Texas Health Science Center, USA)

Treatment of Cryptococcal Disease William E. Dismukes (Univ. of Alabama, USA)

Session F Antimicrobial Resistance in the Hospital Setting : Problems and Strategies for Infection Control In conjunction with Philippine Society for Microbiology and Infectious Diseases

Growing Problems of Antimicrobial Resistance among Nosocomial Pathogens Po-Ren Hsueh (National Taiwan Univ., Chinese Taipei)

MRSA : A Continuing Problem in the Hospital Li Jia Tai (Peking Univ., P.R.China)

Control of Antimicrobial Resistance in the Hospital : Infection Control Strategies Wing Hong Seto (Queen Mary Hospital, P.R. China)

Control of Antimicrobial Resistance in the Hospital : Strategies for Antimicrobial Uses Victor Lim (Institute of Medical Research, Malaysia)

Session G Glycopeptide-Resistant S. aureus & Community-Acquired MRSA In Conjunction with HongKong Society for Infectious Diseases

Community-Acquired MRSA : is it a real threat? Donald J. Lyon (Prince of Wales Hospital, P.R. China)

Genomic View of Virulence and Resistance in Community Acquired MRSA Keiichi Hiramatsu (Juntendo Univ., Japan)

Vancomycin-Resistant S. aureus : Now & Future Keiichi Hiramatsu (Juntendo Univ., Japan)

Mechanism of Glycopeptide Resistance Longzhu Cui (Juntendo Univ., Japan)

Session H Current Issues on HIV Treatment & Drug Resistance

Anti-Retroviral Therapy in the Beginning of the 21st Century Merle Sande (Univ. of Utah, USA)

Monitoring of Anti-Retroviral Resistance Chris Birch (Victorian Infectious Diseases Reference Laboratory, Australia)

New Therapeutic Agents against HIV/AIDS Zelalem Temesgen (Mayo Clinic, USA)

HIV Vaccines in the Future Young Chul Sung (POSTECH, Korea)

Session I Problems in Antimicrobial Treatment in Children : Pediatric Perspectives on Resistance In conjunction with Infectious Diseases Association of Thailand / Philippine Society for Microbiology and Infectious Diseases / Korean Society of Pediatric Infectious Diseases

Enteric Infections Nancy Henry (Mayo Clinic, USA)

Current Issues in Bacterial Meningitis Among Infants and Children Jung Soo Kim (Chonbuk National Univ., Korea)

Are interventions aiming at reduction of antibiotic use effective against antibiotic resistance in children? Ron Dagan (Soroka Univ. Medical Center, Israel)

Immunotherapy of Neonatal Infections Kwang Sik Kim (Johns Hopkins Univ., USA)

Keynote Lectures (2) Future Stragegies for Antimicrobial Therapy in the 21st Century

Global strategies against Antimicrobial Resistance in the 21st Century : WHO Perspectives Philip G. Jenkins (World Health Organization, Switzerland)

Appropriate Use of Antimicrobial Agents : PK/PD Approach William A. Craig (Univ. of Wisconsin, USA)

Clinical Impact of Antimicrobial Resistance for the Past Half Century Walter R. Wilson (Mayo Clinic, USA)

Governmental Role for Control of Antimicrobial Resistance Gun-Jo Woo (Korea Food & Drug Administration,Korea)

Session J New Antimicrobial Agents In Conjunction with Korean Society for Chemotherapy

Novel Beta-Lactam Agents Donald E. Low (Mount Sinai Hospital, Canada)

Beta-Lactamase inhibitors Karen Bush (Johnson & Johnson Pharmaceutical Research & Development, USA)

Novel Bridged Ketolide Antibiotic Yat Sun Or (Enanta Pharmaceuticals, Inc.,USA)

New Drug Classes vs. Nosocomial Gram-Positive Bacteria David M. Livermore (Central Public Health Laboratory, U.K.)

Session K Genomics and Proteomics for Development of Novel Antibiotics

Comprehensive Approaches to Search for Novel Antibiotics Sunghoon Kim (Seoul National Univ., Korea)

Protein Structural Genomics for Drug Discovery Thomas Terwilliger  (Los Alamos National Laboratory, USA)

Structural Chemogenomics for the Discovery of Novel Antibiotics Seonggu Ro (CrystalGenomics, Inc., Korea)

Microbial Genomics and Drug Discovery Garry Myers (The Institute for Genomic Research, USA)

Session L Novel Vaccines on the Horizon : New hopes against resistance?

Staphylococcal Vaccines Jean C. Lee (Harvard Medical School, USA)

Pneumococcal Vaccines Keith P. Klugman (Emory Univ., USA)

Future Vaccines against Enteric Pathogens John Clemens (International Vaccine Institute, USA)

Pseudomonas Vaccine : from Bench to Bedside Jang Yun Lee (CJ Corp., Korea)